Skip to content

Early action needed to prevent treatment failure, Nigerian research on detectable virus levels shows

Andrey_Popov/Shutterstock.com

After viral rebound, dolutegravir-based treatment more likely to suppress HIV

Dr Andrew Hill presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.

Low-level HIV and viral load blips are important warning signals, European study finds

Jarun Ontakrai/Shutterstock.com

Simple changes in clinic processes can yield big improvements in viral load testing, Malawi study shows

Andrey_Popov/Shutterstock.com

Disconnect between awareness and belief in accuracy of U=U in Italy

U=U campaign posters by Lega Italiana per la Lotta contro l'Aids (LILA).

Will increasing viral load testing reduce HIV transmission through breast milk in low- and middle-income countries?

ValeriaRodrigues/Pixabay

Dolutegravir-based regimens result in sustained viral suppression, despite lower adherence and treatment interruptions

A dolutegravir pill

CD4 count below 500 or detectable viral load raise the risk of severe COVID-19 for people with HIV

Photo by Gustavo Fring from Pexels

Viral suppression in Uganda improved by more viral load tests, done faster

Slide from Dr Vivek Jain's presentation to IAS 2021.